Skip to main content
SPRY logo

SPRY · ARS Pharmaceuticals, Inc. · Holdings

Track SPRY — free
$4.03 -0.01 (-0.12%)
Market Cap
$397.79M
Shares
99.45M
Volume · Oct 26 414.67K Avg daily vol (3M) 1.74M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 209
Total Value: $728,007,598
Total Shares: 91,051,848
Showing 1–100 of 215 holdings by value · page 1 of 3

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 208 13F filers
Top Holder
11.9%
Sep 2023 → Jun 2026 · range 11.5% – 18.3%
of institutional value
Top 5
44.5%
Sep 2023 → Jun 2026 · range 41.8% – 63.2%
of institutional value
Top 10
65.5%
Sep 2023 → Jun 2026 · range 59.5% – 82.1%
of institutional value
HHI
548
Sep 2023 → Jun 2026 · range 494 – 1,051
Broadly held

Who Holds SPRY

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 208 filers, like-for-like change -3.7%; actively managed books -4.9%; index-like books +0.7%.

Holder type Share Filers Change
Registered adviser 67.9% 109 -4.6%
Exempt adviser 0.8% 3 -26.0%
Adviser 5.6% 4 -5.6%
Bank 8.3% 12 +1.3%
Insurer 0.1% 3 new
Broker-dealer 0.0% 2 -29.0%
Registered fund 1.3% 1 +55.8%
Benefit plan 0.1% 2 -52.1%
Non-US 0.7% 8 +6.2%
Holding company 11.6% 7 +0.2%
Unknown 3.7% 57 -13.4%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-03-31 13F and 1 holder with no observed 2026-06-30 13F. Compared across CIK changes: JANUS HENDERSON GROUP PLC continues as Jupiter Topco LLC.

Conviction and Crowding

208 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
4
1.92% of filers hold it in their top 10
Mar 31, 2026: 4
Holders above 5%
1
median weight 0.001%
Mar 31, 2026: 1
Crowding
56.3%
of shares outstanding, 99th percentile
Mar 31, 2026: 59.1%
Private-fund advisers
55.3%
of shares outstanding
Institutional ownership
91.2%
168.5% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
65.8%
of 13F shares, Herfindahl 0.055
Active holders
-4.9%
like-for-like share change of active filers
5% stakes on record
5
3 13D, 2 13G (2 institutional, 0 passive, 0 exempt)
How long holders have held it value-weighted 11.2 quarters
Under 1 year 24.2% 1 to 3 years 27.1% 3 years or more 48.7% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $5,211,373 (1 buying, 1 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$9.28
estimated per share
Mar 31, 2026: $9.60
Quarter-end price
$8.01
implied by 13F values
Estimated gain or loss
-13.7%
price against the estimated cost
Estimated at a loss
66.8%
of costed 13F value

Estimated cost covers 75.0% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies SPRY's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 MLYS Mineralys Therapeutics, Inc. 11
2 MNPR Monopar Therapeutics 6
3 SNDX Syndax Pharmaceuticals Inc 8
4 EQ Equillium, Inc. 4
5 EWTX Edgewise Therapeutics, Inc. 7
6 BCRX Biocryst Pharmaceuticals Inc 6
7 ACET Adicet Bio, Inc. 3
8 PRLD Prelude Therapeutics Inc 3
9 CTNM Contineum Therapeutics, Inc. 5
10 NAMS NewAmsterdam Pharma Co N.V. 6

Shareholder Targets

13F filers that own its peers but not SPRY, quarter ended Jun 30, 2026

Found through its holder-overlap peers: MLYS, MNPR, SNDX, EQ, EWTX, BCRX, ACET, PRLD, CTNM, NAMS, ARDX, MREO, ANNX, LXEO, CRBP, EDIT, VERA, ARQT, DSGN, ALEC. 600 filers in all.

# Filer In peers
1 Frazier Life Sciences Management, L.P. Registered adviser, Concentrated $971,374,763 5 held
2 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $452,591,004 3 held
3 SUVRETTA CAPITAL MANAGEMENT, LLC Registered adviser, Diversified active $407,077,499 4 held
4 Kynam Capital Management, LP Registered adviser, Concentrated $345,760,479 5 held
5 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $301,382,595 3 held
6 Polar Capital Holdings Plc Registered adviser, Diversified active $289,870,336 4 held
7 FCPM III SERVICES B.V. Unknown, Concentrated $287,738,062 1 held
8 Driehaus Capital Management LLC Registered adviser, Diversified active $261,809,482 5 held
9 Avoro Capital Advisors LLC Registered adviser, Concentrated $252,544,208 2 held
10 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $243,117,705 3 held

Fund Ownership of SPRY by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.16% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.19% 2,174,444
Index ETFs 8.97% 8,919,435
Active ETFs 0.09% 94,276
Active funds 9.62% 9,563,649
Unclassified 0.01% 7,935
All registered funds 20.88% 20,759,739
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 100 of 215
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 215 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1671858 CUSIP 82835W108 13F (30d) 21 filings 21 filers Visit website Investor relations